TY - JOUR
T1 - Transcatheter Interventions in Patients With Adult Congenital Heart Disease
AU - Tan, Weiyi
AU - Stefanescu Schmidt, Ada C.
AU - Horlick, Eric
AU - Aboulhosn, Jamil
N1 - Funding Information:
Dr Horlick reports a relationship with Abbott Cardiovascular Structural Heart Division that includes consulting or advisory, funding grants, and speaking and lecture fees; Medtronic that includes funding grants; and Edwards Lifesciences Corp that includes funding grants. Dr Aboulhosn reports a relationship with Edwards Lifesciences Corp that includes consulting or advisory, funding grants, speaking and lecture fees, and travel reimbursement; Medtronic that includes consulting or advisory, speaking and lecture fees, and travel reimbursement; and Abbott Cardiovascular Structural Heart Division that includes consulting or advisory, speaking and lecture fees, and travel reimbursement. He is an Editorial Board member of Adult Congenital Heart Association. Drs Tan and Schmidt reported no financial interests. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The research reported has adhered to the relevant ethical guidelines.
Publisher Copyright:
© 2022 The Author(s)
PY - 2022/11/1
Y1 - 2022/11/1
N2 - Patients with congenital heart disease now live well into adulthood because of advances in surgical techniques, improvements in medical management, and the development of novel therapeutic agents. As patients grow older into adults with congenital heart disease, many require catheter-based interventions for the treatment of residual defects, sequelae of their initial repair or palliation, or acquired heart disease. The past 3 decades have witnessed an exponential growth in both the type and number of transcatheter interventions in patients with congenital heart disease. With improvements in medical technology and device design, including the use of devices designed for the treatment of acquired valve stenosis or regurgitation, patients who previously would have required open-heart surgery for various conditions can now undergo percutaneous cardiac catheter-based procedures. Many of these procedures are complex and occur in complex patients who are best served by a multidisciplinary team. This review aims to highlight some of the currently available transcatheter interventional procedures for adults with congenital heart disease, the clinical outcomes of each intervention, and any special considerations so that the reader may better understand both the procedure and patients with adult congenital heart disease.
AB - Patients with congenital heart disease now live well into adulthood because of advances in surgical techniques, improvements in medical management, and the development of novel therapeutic agents. As patients grow older into adults with congenital heart disease, many require catheter-based interventions for the treatment of residual defects, sequelae of their initial repair or palliation, or acquired heart disease. The past 3 decades have witnessed an exponential growth in both the type and number of transcatheter interventions in patients with congenital heart disease. With improvements in medical technology and device design, including the use of devices designed for the treatment of acquired valve stenosis or regurgitation, patients who previously would have required open-heart surgery for various conditions can now undergo percutaneous cardiac catheter-based procedures. Many of these procedures are complex and occur in complex patients who are best served by a multidisciplinary team. This review aims to highlight some of the currently available transcatheter interventional procedures for adults with congenital heart disease, the clinical outcomes of each intervention, and any special considerations so that the reader may better understand both the procedure and patients with adult congenital heart disease.
KW - adult congenital heart disease
KW - congenital cardiac interventions
KW - stenting
KW - transcatheter interventions
KW - transcatheter valve replacement
UR - http://www.scopus.com/inward/record.url?scp=85147102170&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147102170&partnerID=8YFLogxK
U2 - 10.1016/j.jscai.2022.100438
DO - 10.1016/j.jscai.2022.100438
M3 - Review article
AN - SCOPUS:85147102170
SN - 2772-9303
VL - 1
JO - Journal of the Society for Cardiovascular Angiography and Interventions
JF - Journal of the Society for Cardiovascular Angiography and Interventions
IS - 6
M1 - 100438
ER -